ELAB vs FITB · rev $2.0M vs P/E 17, rev $3.37B
Elevai Labs, Inc. Common Stock (ELAB) versus Fifth Third Bancorp (FITB) — a side-by-side from cached financials, not a winner call.
Elevai Labs, Inc. Common Stock (ELAB) is a biotechnology company listed on NASDAQ.
Fifth Third Bancorp (FITB) is a banks - regional company listed on US.
Latest reported ELAB revenue for 2026-06-30 was $2.0M. Net income was -$7.9M. ELAB currently screens at market cap $6.5M.
Latest reported FITB revenue for 2026-06-30 was $3.37B. Net income was $801.0M. Revenue was up 13.5% from 2026-03-31 to 2026-06-30. FITB currently screens at market cap $45.25B and trailing P/E 16.8.
ELAB currently screens at market cap $6.5M. FITB currently screens at market cap $45.25B and trailing P/E 16.8.
Not investment advice. Open the ELAB and FITB stock pages for the full models.
Not investment advice.